2 news items
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
ARCT
7 Mar 24
of long
Earnings Preview: Arcturus Therapeutics
ARCT
6 Mar 24
period, shares are up 152.97%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release
- Prev
- 1
- Next